ANHL01P1: Institutional Pathology Form [reload] NCT00057811 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder:

  1. 8/27/12 8/27/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 6/27/15 6/27/15 -
Uploaded on:

June 27, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

ANHL01P1: Institutional Pathology Form [reload] NCT00057811

No Instruction available.

  1. StudyEvent: ANHL01P1: Institutional Pathology Form [reload]
    1. No Instruction available.
Pathology evaluation
Time sample obtained (One must be chosen)
Method for obtaining tissue samples (Required field)
Source of tissue samples (Required field)
Pathologic diagnosis (Required field)
Immunophenotype (One must be chosen)
Results From Fresh Or Frozen Tissue
Antigen Type
Results from paraffin embedded tissue (One must be chosen)
TDT Method (One must be chosen)
Results From Paraffin Embedded Tissue
SLIDE/TISSUE SUBMISSION: For Central Review? (One must be chosen)
Is any frozen tissue available? (One must be chosen)
Number of hours in fixative before processing
Is there evidence of clonality by gene rearrangement? (Required field)
Ccrr Module For Anhl01p1: Institutional Pathology Form [reload]

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial